Continuous positive airway pressure (CPAP) is a common technique for alleviating respiratory distress in infants with bronchiolitis. Most studies of CPAP have been conducted in an intensive care setting, but a recent trial assessed the feasibility of using CPAP to treat infants with bronchiolitis in a general paediatric ward.
New drug applications approved by US FDA as of 16 - 30 April 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.